3 New Dividend Funds Let You ‘Pick Your Risk’

FlexShares' new trio of "Quality" dividend ETFs allows you to "pick your risk profile," but still doesn't seem to add much spice to the dividend-fund world. More 

6 Call Contenders: Pharmaceuticals

My Power Stock scanner has identified bullish trends for these 6 stocks, all trading near their support. It's the perfect time to initiate a long position or at-the-money calls. More 

3 Generic Drug Stocks to Buy Right Away

Generic drugs are forecast to be the single fastest-growing industry for the next several years. Here are three stocks to profit from this trend. More 

India Drops Patent Bomb on Novartis

India's ruling on a Novartis patent draws a clear line of favor between generic drug companies and Big Pharma. More 

46 Stock Bellwethers on the Move

There is no doubt the upcoming first-quarter earnings announcement season is going to separate the wheat from the chaff and here are 46 stocks with new ratings More 

Put Your Portfolio on Defense

The market's dependence on Fed support is frankly worrying--so for new money, stop chasing the newest, most exciting stocks in favor of defensive consumer staples like KRFT and PM. More 

AstraZeneca Plans 2,300 More Job Cuts

AstraZeneca will trim its payroll by another 2,300 jobs, just days after cutting 1,600 other workers, as part of its latest restructuring. More